-
Dr. Yanhang Gao’s Team: Non-Invasive Screening for ANA-Positive DILI Patients with AIH-Like Histological Features, Aiding in Precise Liver Biopsy!
Drug-induced liver injury (DILI) can mimic all features of acute and chronic liver diseases, including autoimmune hepatitis (AIH). Both conditions exhibit similarities in serology and histology, including the presence of…
-
Dr. Jun Li’s Team: ETS2 as a Potential New Target for the Diagnosis and Treatment of HBV-ACLF, Alleviating Liver Failure Progression by Suppressing Macrophage Immune Inflammatory Response
Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) is a complex syndrome characterized by acute liver failure on the basis of chronic hepatitis B, triggered by various factors, with a short-term…
-
Dr. George-Lau: Advances and Reflections on Hepatitis B and Hepatitis D New Therapies
At the 58th European Association for the Study of the Liver (EASL) Annual Meeting (EASL2023) and the 2023 EASL Congress, one of the highlights was the emergence of new antiviral…
-
ESMO Expert Commentary | Professor Xinxiang Li: Rechallenge with EGFR Inhibitors in ctDNA RAS/BRAF Wild-Type Refractory mCRC Provides New Perspectives for Colorectal Cancer Treatment
Editor’s Note:The European Society for Medical Oncology (ESMO) annual meeting in Madrid, Spain has proceeded as scheduled. “Oncology Frontier” has selected key research reported at ESMO 2023 for commentary by…
-
ESMO 2023 | Professor Man Li: Dato-DXd Multidomain Efficacy Data Released, Bringing Hope for Survival to More Cancer Patients
Editor’s note: Currently, antibody-drug conjugates (ADCs) have become “star drugs” in the field of cancer treatment. Dato-DXd is a novel ADC that consists of a humanized monoclonal antibody targeting Trop-2,…
-
ESMO in 5 Minutes | Professor Man Li: Advances in Early Breast Cancer Treatment
Editor’s Note: The primary goal for early-stage breast cancer patients is cure, and numerous studies have explored treatment strategies based on this objective. In this edition of the ESMO conference,…
-
ESMO Hot Review | Dr. Lu Si and LiLi Mao: Addressing Challenges in the Treatment of Melanoma, Breaking Through the Difficulties of Brain Metastases
Editor’s Note: The 2023 European Society for Medical Oncology (ESMO) Annual Meeting took place in Madrid, Spain as scheduled. What new developments are there in the field of melanoma, which…
-
WCLC 2023 |Dr. Zhu Zhengfei: SBRT Combined with Dual Immune Checkpoint Inhibitors for Advanced NSCLC Achieves a Median OS of 34 Months
The 2023 World Conference on Lung Cancer (WCLC), organized by the International Association for the Study of Lung Cancer (IASLC), was held in Singapore from September 9th to 12th. ” Oncology Frontier” invited Zhu Zhengfei from Fudan University-affiliated Cancer Hospital to comment on the findings of the COSINR study.
Connecting Medical Expertise through Media